EDITHAL

Serial Number 97352213
733

Registration Progress

Application Filed
Apr 7, 2022
Under Examination
Feb 14, 2023
Approved for Publication
Dec 20, 2022
Published for Opposition
Dec 20, 2022
Registered

Attorney Assistance

Important Deadline Approaching

Statement of Use Due - Extension 4 Granted
Due: August 14, 2025 (38 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
97352213
Deadline
August 14, 2025
Description
Statement of Use or 5th Extension Due
Filing Date
April 7, 2022
Published for Opposition
December 20, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Feb 13, 2025
Application
Pending
Classes
042

Rights Holder

Editas Medicine, Inc.

03
Address
11 Hurley Street
Cambridge, MA 02141

Ownership History

Editas Medicine, Inc.

Original Applicant
03
Cambridge, MA

Editas Medicine, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
38 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
August 14, 2025
Extension Available
Until February 14, 2024

Application History

30 events
Date Code Type Description
Feb 14, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2025 EX4G S SOU EXTENSION 4 GRANTED
Feb 13, 2025 EXT4 S SOU EXTENSION 4 FILED
Feb 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 8, 2024 EXT3 S SOU EXTENSION 3 FILED
Aug 8, 2024 EX3G S SOU EXTENSION 3 GRANTED
Aug 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2024 EX2G S SOU EXTENSION 2 GRANTED
Jan 25, 2024 EXT2 S SOU EXTENSION 2 FILED
Jan 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 14, 2023 EX1G S SOU EXTENSION 1 GRANTED
Jul 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 14, 2023 EXT1 S SOU EXTENSION 1 FILED
Feb 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 PUBO A PUBLISHED FOR OPPOSITION
Nov 30, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 25, 2022 GNRT F NON-FINAL ACTION E-MAILED
Jul 25, 2022 CNRT R NON-FINAL ACTION WRITTEN
Jul 20, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 12, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development services; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals for the treatment of Beta Thalassemia

Classification

International Classes
042